Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price fell 3.5% during trading on Tuesday . The stock traded as low as $1.0950 and last traded at $1.11. 427,366 shares were traded during mid-day trading, an increase of 537% from the average session volume of 67,097 shares. The stock had previously closed at $1.15.
Cardiol Therapeutics Stock Down 3.5%
The company has a 50 day moving average price of $1.34 and a 200 day moving average price of $1.13.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
